scispace - formally typeset
I

Isabelle Boutron

Researcher at University of Paris

Publications -  287
Citations -  71970

Isabelle Boutron is an academic researcher from University of Paris. The author has contributed to research in topics: Randomized controlled trial & Systematic review. The author has an hindex of 64, co-authored 257 publications receiving 31086 citations. Previous affiliations of Isabelle Boutron include Paris Diderot University & Paris-Sorbonne University.

Papers
More filters
Journal ArticleDOI

Research response to coronavirus disease 2019 needed better coordination and collaboration: a living mapping of registered trials.

Van Thu Nguyen, +76 more
TL;DR: This living mapping analysis showed that COVID-19 trials have relatively small sample size with certain redundancy in research questions, and most trials were registered when the first peak of the pandemic have passed.
Journal ArticleDOI

Sharing of Data From Industry-Funded Registered Clinical Trials

TL;DR: To evaluate the completeness of data sharing on CSDR, it is investigated the proportion of randomized clinical trials (RCTs) registered at ClinicalTrials.gov that were listed at CSDR.
Journal ArticleDOI

Interventions to improve adherence to reporting guidelines in health research: a scoping review protocol.

TL;DR: A scoping review of interventions to improve adherence to reporting guidelines in health research that have been evaluated or suggested, in order to inform future interventions, is conducted.
Journal ArticleDOI

Geographical Representativeness of Published and Ongoing Randomized Controlled Trials. The Example of: Tobacco Consumption and HIV Infection

TL;DR: An important underrepresentation of low- and middle-income countries is highlighted in currently available evidence (RCTs included in systematic reviews) and awaiting evidence (registered ongoing RCTs) for reducing or stopping tobacco use and treating or preventing HIV infection.
Journal ArticleDOI

Should aggregate scores of the Medical Outcomes Study 36-item Short Form Health Survey be used to assess quality of life in knee and hip osteoarthritis? A national survey in primary care

TL;DR: The results suggest that aggregate scores from the PCS and MCS of the SF-36 as they are currently defined may not be optimal for used in hip and knee OA patients to assess health-related quality of life.